In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Synetic CareInsite IPO To Proceed Following Decision In Merck Litigation

Executive Summary

A New Jersey state court's denial of Merck's preliminary injunction request against Synetic has cleared the way for the company to proceed with a proposed spin-off of its health care e-commerce subsidiary CareInsite, Inc.

You may also be interested in...



Merck-Medco Management Transition Complete: Clark Succeeds Lofberg

Merck-Medco will be headed by a veteran Merck executive as the PBM division moves to a new level of prominence within the pharmaceutical company parent.

Merck-Medco Management Transition Complete: Clark Succeeds Lofberg

Merck-Medco will be headed by a veteran Merck executive as the PBM division moves to a new level of prominence within the pharmaceutical company parent.

Healtheon Paying $5 Bil. For CareInsite, Symbolic Role As New Medco

Healtheon/WebMD's acquisition of Medical Manager/CareInsite will allow Healtheon to inherit the image of the next Medco in the physician connectivity field.

Related Content

UsernamePublicRestriction

Register

PS034019

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel